ResearcherUniversity of Tennessee Health Science CenterNo recent work listed

Syed M. Hussain

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8401-3244; OpenAlex author ID A5046493408. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression. Co-author DOI 10.1007/s13402-021-00594-0 ↗
TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s12029-018-00195-5 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marcus A. Alvarez · 2 shared papers, 2019–2021 · strength 0.24
- Paper TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1007/s12029-018-00195-5 ↗
- Paper Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression. DOI 10.1007/s13402-021-00594-0 ↗
Evan Scott Glazer · 2 shared papers, 2019–2021 · strength 0.24
- Paper TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1007/s12029-018-00195-5 ↗
- Paper Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression. DOI 10.1007/s13402-021-00594-0 ↗
Paxton Vandiver Dickson · 1 shared paper, 2021 · strength 0.11
- Paper Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression. DOI 10.1007/s13402-021-00594-0 ↗
Danny Yakoub · 1 shared paper, 2021 · strength 0.11
- Paper Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression. DOI 10.1007/s13402-021-00594-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.